Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
about
Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.
P2860
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Persistent risk of HBV reactiv ...... th an anti-HBc-positive donor.
@en
Persistent risk of HBV reactiv ...... th an anti-HBc-positive donor.
@nl
type
label
Persistent risk of HBV reactiv ...... th an anti-HBc-positive donor.
@en
Persistent risk of HBV reactiv ...... th an anti-HBc-positive donor.
@nl
prefLabel
Persistent risk of HBV reactiv ...... th an anti-HBc-positive donor.
@en
Persistent risk of HBV reactiv ...... th an anti-HBc-positive donor.
@nl
P2093
P50
P1476
Persistent risk of HBV reactiv ...... th an anti-HBc-positive donor.
@en
P2093
A Battisti
A Ricciardi
D Di Carlo
G De Angelis
G Maffongelli
L Colagrossi
M Andreoni
P304
946.e1-946.e8
P356
10.1016/J.CMI.2016.07.021
P577
2016-07-27T00:00:00Z